Development of techniques for gastrojejunal bypass surgery in obese mice

Microsurgery

Volumn 30, Issue 4, 2010, Pages 289-295

  Lan, Zhu ^a   Zassoko, Roman ^b   Liu, Weihua ^a   Garcia, Bertha ^a   Sun, Hongtao ^a   Wang, Rennian ^a,c   Wang, Hao ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARIATRIC SURGERY; BODY WEIGHT; CONTROLLED STUDY; END TO END ANASTOMOSIS; GASTROJEJUNAL BYPASS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HISTOLOGY; IMPAIRED GLUCOSE TOLERANCE; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; OBESITY; OPERATION DURATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SURVIVAL RATE; WEIGHT REDUCTION;

ANASTOMOSIS, SURGICAL; ANIMALS; BILIOPANCREATIC DIVERSION; BIOPSY, NEEDLE; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; DUODENUM; GASTRIC BYPASS; IMMUNOHISTOCHEMISTRY; JEJUNUM; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; RANDOM ALLOCATION; RISK FACTORS; SURVIVAL RATE; WEIGHT LOSS;

EID: 77952995406     PISSN: 07381085     EISSN: 10982752     Source Type: Journal    
DOI: 10.1002/micr.20746     Document Type: Article

References (12)

1. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999;131:281-303. (Pubitemid 29383658)
2. Liebl A. Challenges in optimal metabolic control of diabetes. Diabetes Metab Res Rev 2002;18 (Suppl 3):S36-S41. (Pubitemid 35256583)
3. Evans A, Krentz AJ. Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus. Drug Saf 1999;21:7-22. (Pubitemid 29355510)
4. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: A systematic review and meta-analysis. JAMA 2004;292:1724-1737. (Pubitemid 39346675)
5. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: Systematic review and meta-analysis. Am J Med 2009;122:248-256.
6. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, MacLean LD. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004;240:416-423; discussion 423-1414 (Pubitemid 39121336)
7. Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: A population-based analysis. J Am Coll Surg 2004;199:543-551.
8. Liu W, Zassoko R, Mele T, Luke P, Sun H, Liu W, Garcia B, Jiang J, Wang H. Establishment of duodenojejunal bypass surgery in mice: A model designed for diabetic research. Microsurgery 2008;28:197-202. (Pubitemid 351458270)
9. Olfert ED, Cross BM, McWilliam AA. Responsibility for the care and use of experimental animals. In: Olfert ED, Cross BM, McWilliam AA, editors. Guide to the Care and Use of Experimental Animals, Vol. 1. Ottawa: Association of Universities and Colleges of Canada; 1993. pp 1-14.
10. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: A new perspective for an old disease. Ann Surg 2004;239:1-11. (Pubitemid 38176365)
11. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M, Marescaux J. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244:741-749. (Pubitemid 44629948)
12. Mistry SB, Omana JJ, Kini S. Rat models for bariatric surgery and surgery for type 2 diabetes mellitus. Obes Surg 2009;19:655-660.